INTRODUCTION {#h0.0}
============

Our microbes contribute to several important functions for the body. For example, the gut microbiota helps us to digest food and produce vitamins and has an important role in the development of the host physiology and gut immune system ([@B1], [@B2]). The gut microbiota composition has also been associated with disease manifestations, such as atherosclerosis, metabolic disorders, irritable bowel syndrome, and inflammatory bowel disease ([@B3][@B4][@B9]). In particular, in Crohn's disease, patients have been observed to have a disturbed composition and reduced diversity of the intestinal microbiota ([@B10], [@B11]). A recent study proposed that the human gut microbiota can be stratified into 3 major clusters, termed enterotypes, and these enterotypes are defined by a predominance of the genera *Bacteroides* (enterotype 1), *Prevotella* (enterotype 2), and *Ruminococcus* (enterotype 3) ([@B12]). In studies of other cohorts, less clear dominance of the genus *Ruminococcus* and stronger clustering around the genera *Bacteroides* and *Prevotella* have been found ([@B5], [@B13]), yet both long-term diet and disease (atherosclerosis) have been linked to these enterotypes ([@B5], [@B13]).

One important function of the microbiota is colonization resistance. However, very little is known about how the human gut microbiota influences susceptibility to infection caused by enteropathogens. In one animal study, transplantation of microbiota from mouse strains refractory to *Citrobacter rodentium* infection protected susceptible mouse strains from an otherwise lethal infection, suggesting that the protective effect against pathogen colonization and enterocolitis development was dependent on the microbial community composition ([@B14]). Another mouse study indicated that a microbiota with a low complexity or the disturbance of the gut microbial community structure with antimicrobials predisposed the subject to the development of *Salmonella enterica*-induced enterocolitis ([@B15]). Stecher et al. ([@B16]) in 2010 found that the colonization efficiency of *S. enterica* correlated with the levels of intestinal *Escherichia coli* before infection in C57Bl/6 mice and that mice with high levels of lactobacilli were more prone to colonization by a *Lactobacillus reuteri* strain, suggesting that the presence of closely related species in a host's microbiota can facilitate colonization by another related bacterial species ([@B16]).

*Campylobacter* is the most common cause of human bacterial enteritis in developed countries, with *Campylobacter jejuni* and *Campylobacter coli* causing the vast majority of the infections. Mice are naturally resistant to *Campylobacter* infection, and challenge leads to only transient colonization. However, mice with a humanized intestinal microbiota could be successfully colonized with *C. jejuni*, which resulted in intestinal inflammation, further indicating that the constitution of the microbiota might influence resistance to colonization and induction of inflammation ([@B17]). Characterization of the microbiotas of mice later infected with *C. jejuni* revealed that elevated numbers of intestinal *E. coli* organisms reduced resistance to colonization by *C. jejuni* ([@B18]).

In the present prospective study, we assessed the compositions of the fecal microbiotas of poultry abattoir workers in association with *Campylobacter* infection. These workers were *Campylobacter* culture negative at the beginning of the study and were regularly monitored, with fecal samples obtained for *Campylobacter* culture and analysis of the microbiota composition during the peak season for *Campylobacter*-positive chicken flocks in Sweden. We found clear differences in the fecal microbiota compositions between participants who later became *Campylobacter* positive during the study and those who remained negative. Intraindividual stability in the microbiota over time was significantly lower among participants who became *Campylobacter* positive.

(Part of this study was presented at the 17th International Workshop on *Campylobacter*, *Helicobacter* and Related Organisms, Aberdeen, Scotland, 15 to 19 September 2013, and at the 7th Finnish Gut Day, Helsinki, Finland, 24 January 2014.)

RESULTS {#h1}
=======

Composition of the fecal microbiota. {#h1.1}
------------------------------------

The gut microbiota composition was analyzed in fecal samples collected prospectively from 24 poultry abattoir workers during the peak season of *Campylobacter* infection in Sweden. 454 pyrosequencing of 16S amplicons from the fecal samples generated a total of 221,238 sequences, with an average of 2,729 sequences per sample (range, 1,409 to 12,785; 90% of the samples had more than 2,110 sequences). Phylogenetic classification revealed that the prevalences of the four major phyla (*Firmicutes*, *Bacteroidetes*, *Actinobacteria*, and *Proteobacteria*) varied considerably between the samples. We used principal-component analysis (PCA) in order to identify relationships among samples with regard to their microbial community structure. The PCA identified one individual in the sample set as an outlier, and therefore this particular individual was excluded from the PCA. Analysis of the sequence data, classified to the genus level from the remaining individuals, revealed that primarily three taxonomic groups of bacteria created gradients in the ordination. Interestingly, these taxonomic groups were *Bacteroides*, *Prevotella*, and unclassified *Ruminococcaceae* ([Fig. 1](#fig1){ref-type="fig"}), which also have been reported to represent main contributors to the different enterotypes in the human gut ([@B12]). The samples did, however, not cluster as distinct enterotypes ([Fig. 1](#fig1){ref-type="fig"}).

![Bi-plot from a principal-component analysis (PCA) of 454 pyrosequencing data classified to the taxon level. Each sample obtained from the poultry abattoir workers is represented by a colored circle, and the variables are shown as green vectors. Eigenvalues for components 1 and 2 are shown in parentheses. The colors of samples represent different groups, as follows: red, individuals who became *Campylobacter* positive; blue, individuals who remained *Campylobacter* negative; and gray, individuals with earlier reported *Campylobacter* infection. Abbreviations represent the phylogenetic origins of the different taxa, as follows: B, *Bacteroidetes*, and F, *Firmicutes*.](mbo0041419480001){#fig1}

The composition of the microbiota correlates with a positive *Campylobacter* culture. {#h1.2}
-------------------------------------------------------------------------------------

In this study, *Campylobacter*-positive samples were obtained from seven participants, all but one with asymptomatic infection, whereas 17 remained culture negative. We analyzed differences in the compositions of the microbiotas between individuals who became *Campylobacter* positive and those who remained negative. There were no significant differences in taxon diversity between the two groups (data not shown). However, coloring of samples in the PCA plot showed that most of the samples from *Campylobacter*-positive individuals (red) clustered with only little overlap with the samples from *Campylobacter*-negative individuals. A nonparametric multivariate analysis of variance (np-MANOVA) showed that this clustering pattern was significant, with differences between those who became positive and those who remained culture negative (*P* = 0.017). In addition, samples from individuals with an earlier-reported *Campylobacter* infection (gray) clustered primarily together with those from *Campylobacter*-positive individuals. Interestingly, in the PCA plot, it seemed like the clustering of the samples of the individuals who became culture positive was linked with the abundance of *Bacteroides* species ([Fig. 1](#fig1){ref-type="fig"}). Therefore, we further investigated specifically which microbial taxa differed between the *Campylobacter*-positive and -negative individuals. As indicated in the PCA, the abundance of *Bacteroides* sequences was higher in *Campylobacter*-positive individuals (*P* = 0.007, Mann-Whitney test) ([Fig. 2](#fig2){ref-type="fig"}). In addition, this particular group was associated with higher abundances of *Escherichia* (*P* = 0.002), *Phascolarctobacterium* (*P* = 0.017), and *Streptococcus* (*P* = 0.034) sequences than was the *Campylobacter*-negative group (Mann-Whitney's test). Participants who remained *Campylobacter* negative (blue) had higher abundances of sequences classified as *Clostridiales* (*P* = 0.017), unclassified *Lachnospiraceae* (*P* = 0.008), and *Anaerovorax* (*P* = 0.015, Mann-Whitney test) ([Fig. 2](#fig2){ref-type="fig"}). Sequences classified as *Campylobacter* spp. were found only in low abundances (below 0.2%) and only in three samples of the same number of individuals who became *Campylobacter* culture positive in the present study.

![Relative abundances of taxa that differ significantly between individuals who became *Campylobacter* positive (red) and those who remained negative (blue) (Mann-Whitney's test). Error bars show standard errors of the means. Abbreviations represent the phylogenetic origin of the different taxa as follows: B, *Bacteroidetes*; F, *Firmicutes*; and P, *Proteobacteria*. uncl., unclassified.](mbo0041419480002){#fig2}

Stability of the gut microbiota composition over time. {#h1.3}
------------------------------------------------------

The stability of a participant's gut microbiota over time was assessed by calculating Bray, Curtis similarities from samples collected from the same individual at intervals of 1, 2, 3, or \>5 months. Comparisons of intraindividual samples separated by \>5 months generally yielded larger differences than short-term intervals. When *Campylobacter*-positive and -negative participants were analyzed together, the similarity index for samples separated by \>5 months was significantly lower than those separated by 1 (*P* \< 0.001), 2 (*P* \< 0.05), or 3 (*P* \< 0.05, Kruskal-Wallis) months ([Fig. 3](#fig3){ref-type="fig"}). However, when the *Campylobacter*-positive participants were compared to -negative participants that had not reported previous *Campylobacter* infection, the similarity index for intraindividual samples separated by \>5 months was significantly lower for the group that became *Campylobacter* positive (*P* \< 0.005, Kruskal-Wallis). In fact, most of the drop in the similarity index was explained by this group, as the similarity index for samples separated by \>5 months within the control group did not significantly differ from comparisons over shorter time intervals (*P* = 0.25, Kruskal-Wallis). Furthermore, in the *Campylobacter*-positive group, the follow-up sample obtained in February accounted for the decreased similarity index, as the comparisons over shorter time periods yielded only small differences ([Fig. 3](#fig3){ref-type="fig"}). We analyzed whether this drop could be explained by changes in the abundances of certain taxonomic groups of bacteria in the last sample obtained in February. However, we could not find any specific bacterial taxa that had consistently increased or decreased among all *Campylobacter*-positive individuals in the long-term follow-up sample.

![Box plot showing the distribution of similarity scores for intraindividual comparisons of community profiles from samples separated 1, 2, 3, or \>5 months in time. Box plots in black show the distribution of similarity scores from all samples, whereas box plots in red and blue show distributions of similarity scores from individuals who became *Campylobacter* positive (red; Campy +) and those who remained negative (blue; Campy −). Significance was tested using the Kruskal-Wallis test with the Mann-Whitney test as the *post hoc* test. \*, *P* value below 0.05; \*\*\*, *P* value below 0.005. The horizontal line in the box plot represents the median value, and the box is drawn from the 25th to 75th percentiles. Whiskers show minimum and maximum values, and circles represent outliers.](mbo0041419480003){#fig3}

DISCUSSION {#h2}
==========

The concept that the microbiota can protect the host from colonization by enteric pathogens, i.e., lead to colonization resistance, has been known for a long time ([@B19]), but few studies have been successful in generating evidence to define key species or functions involved. The recent advances in sequencing technology have made such analyzes possible ([@B20]), and a few animal studies have indicated a role of the microbiota in colonization resistance ([@B16][@B17][@B18], [@B21], [@B22]). We aimed to address the role of the human fecal microbiota in colonization resistance and prospectively followed staff members at chicken abattoirs with analyses of their fecal microbiota compositions before, during, and after the summer peak of *Campylobacter* colonization of chicken flocks in Sweden. We identified significant differences in the microbiota compositions between individuals who became *Campylobacter* positive during the study and those who remained negative. This is as far as we know the first microbiota study of resistance to *Campylobacter* colonization in humans.

We found that the main human enterotypes, namely, *Bacteroides*, *Prevotella*, and unclassified *Ruminococcaceae*, created gradients in our material, indicating that the compositions of the fecal microbiotas among the abattoir workers in this study did not differ dramatically from those of other cohorts studied ([@B5], [@B12]). However, we found significant differences in the abundances of certain bacterial taxa between the individuals who became culture positive for *Campylobacter* and those who remained negative. Importantly, these differences not merely were due to the presence or absence of *Campylobacter* in the samples but were evident in all consecutive fecal samples of the individuals, both before and after the *Campylobacter*-positive sample, indicating a general difference in the fecal microbial community structures between individuals who became positive for *Campylobacter* and those who remained negative. The taxa *Bacteroides and Escherichia* were present in significantly higher proportions in the positive group ([Fig. 2](#fig2){ref-type="fig"}). A recent study linked the abundance of *E. coli* with a gastrointestinal dysfunction in cystic fibrosis patients ([@B23]). Interestingly, recent studies on resistance to *Campylobacter* colonization in experimentally infected mice showed that colonization with *C. jejuni* was associated with significantly elevated numbers of both intestinal *E. coli* and *Bacteroides*/*Prevotella* organisms ([@B17], [@B18]). In addition, oral supplement of *E. coli* to mice increased the susceptibility to *Campylobacter* infection, and furthermore, high abundances of *Proteobacteria* in the fecal microbiota have previously been reported to facilitate colonization by bacterial pathogens of the same phylum ([@B16], [@B18]). Whether the correlation between certain bacterial genera and susceptibility to *Campylobacter* infection is due to a direct inhibitory effect of the commensals or due to their effects on the intraluminal milieu remains to be studied. We also found higher proportions of *Phascolarctobacterium* and *Streptococcus* sequences in individuals who became positive for *Campylobacter*, and these bacterial taxa have previously not been associated with colonization resistance.

The gut microbiota is generally considered to be stable over time in healthy adults ([@B24]). This is in agreement with our finding that the intraindividual stabilities of the fecal microbiotas were similar in samples separated in time by 1, 2, or 3 months. In addition, samples from individuals who remained *Campylobacter* culture negative also had a stable microbiota when samples separated more than 5 months in time were compared. However, among the individuals who became positive for *Campylobacter* during the study, the similarity index was significantly reduced when samples separated by \>5 months were compared, indicating that the microbiota had changed in composition. The fact that the last follow-up sample accounted for most of this change suggests that *Campylobacter* positivity had caused long-term alterations in the fecal microbiota compositions of these individuals. Possible reasons for such a change might be related either to bacterial competition or to the immune responses of the *Campylobacter*-positive participants. The fact that we did not find consistent changes in the abundances of certain bacterial taxa in all *Campylobacter*-positive participants suggests that induction of such changes is complex and might have different outcomes in different individuals in terms of which bacterial species are affected.

Microbial diversity has also been linked with colonization resistance. Stecher et al. in 2010 studied the impact of microbial diversity on the resistance to colonization in mice and found that a microbiota with a high complexity had better resistance to *Salmonella* infection than both a low-complexity microbiota and that after antibiotic treatment ([@B16]). Our results showed no difference in levels of fecal microbial diversity between individuals who became *Campylobacter* positive and those who remained negative. It is, however, not possible to rule out the importance of diversity. In our study, all but one of the culture-positive individuals were asymptomatic, and all of them had a microbial diversity similar to that of healthy noninfected individuals.

The risk of acquiring *Campylobacter* infection at a chicken abattoir is high ([@B25]), especially during the summer peak in June to September, when approximately 25 to 40% of the slaughtered chicken flocks are *Campylobacter* positive in Sweden ([@B26]). This suggests that all staff members must be exposed to *Campylobacter* at several occasions during the seasonal peak. Therefore, the chicken abattoir workers make an interesting cohort for studying resistance to *Campylobacter* infection. Although the number of participants in the present study was low, the findings were clear enough to reach statistical significance. With the background evidence from mouse studies, we find it reasonable to assume that the higher abundances of both *Bacteroides* and *Escherichia* species were associated with an increased susceptibility to the establishment of *Campylobacter* infection, as shown by positive fecal cultures in the abattoir workers. Furthermore, we identified significant alterations in the compositions of the gut microbiotas after 5 months in the individuals who became *Campylobacter* positive. Whether the microbiota composition, alone or together with the immune status of the individuals, also plays a significant role in the eradication of *Campylobacter* from the intestine remains to be studied.

In conclusion, elevated proportions of *Bacteroides* and *Escherichia* species in the gut microbiota might predispose humans to *Campylobacter* infection, and *Campylobacter* infection can cause long-term alterations in the composition of the human gut microbiota. To the best of our knowledge, this is the first microbiota study presenting evidence of resistance to *Campylobacter* colonization/infection in humans.

MATERIALS AND METHODS {#h3}
=====================

Participants and sample collection. {#h3.1}
-----------------------------------

In this prospective study, a total of 31 abattoir workers (18 women and 13 men) at 3 different poultry abattoirs in Sweden were included. Fecal samples were collected once a month during the summer months June to September of 2010, with an additional follow-up sample at the end of February 2011. On each sampling occasion, one fecal sample for *Campylobacter* culture and one sample for analysis of microbiota were collected by the participants and sent to the Clinical Microbiology Laboratory at Uppsala University Hospital. Fecal samples were cultured immediately upon arrival for *Campylobacter* by routine methods, and samples for microbiota analysis were stored at −70°C for subsequent analysis. Information on age, gender, length of employment at the abattoir, previously documented *Campylobacter* infections, and use of antimicrobial therapy, as well as gastrointestinal disorders and symptoms, was obtained by questionnaires filled out by the participants. All fecal samples were *Campylobacter* culture negative at the beginning of the study. During the study, 7 participants became culture positive for *Campylobacter*. One additional abattoir worker was enrolled because he fell ill and was diagnosed with *Campylobacter* infection at the county hospital of the region where he lived. None of the other infected participants reported any symptoms of *Campylobacter* infection. Of the 31 participants, 1 *Campylobacter*-positive individual was excluded due to too little fecal material for microbiota analysis and, for another *Campylobacter*-positive individual who was treated with antimicrobials, the follow-up samples after antimicrobial therapy were excluded from analysis. Of the culture-negative participants, 2 were excluded because they had gastrointestinal disorders (1 had celiac disease, and 1 reported symptoms related to irritable bowel syndrome). Two were excluded because early antimicrobial therapy was initiated, and the last follow-up sample from one individual was excluded due to antimicrobial therapy in connection with that sample. Furthermore, 2 were excluded because of too little fecal material for microbiota analysis. In total, samples from 7 *Campylobacter*-positive participants and 17 *Campylobacter*-negative participants were analyzed for fecal microbiota composition. Five participants (1 *Campylobacter* positive) had worked at the abattoir ≤1 month from the beginning of the study and had not reported any previously documented *Campylobacter* infection. Six participants (2 of whom were *Campylobacter* positive in the present study) had reported previously documented *Campylobacter* infection. None of the individual characteristics collected in the questionnaires was associated with *Campylobacter* positivity (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material).

The study was approved by the regional board of the ethical committee at Uppsala University. All participants gave their written informed consent.

Bacterial isolation and typing. {#h3.2}
-------------------------------

Fecal samples were cultured for *Campylobacter* by routine methods on modified charcoal cefoperazone deoxycholate (mCCDA) agar plates (Oxoid, Basingstoke, England), and isolates were originally identified by colony appearance, oxidase testing, and microscopy. Five isolates were further subtyped by PCR analysis ([@B27]), 4 of them to *C. jejuni* and 1 to *C. lari*. Two isolates were not available for subtyping.

Preparation of samples for 454 pyrosequencing. {#h3.3}
----------------------------------------------

DNA was extracted from 250-mg fecal samples using the Mo Bio PowerSoil DNA kit (Solana Beach, CA, USA) according to the manufacturer's instructions. The only modification from the kit protocol was that the bead-beating step was performed twice for 45 s at level 5 on a FastPrep-24 (MP Biomedicals, Solon, OH). The bacterial primers Bakt_341F (CCTACGGGNGGCWGGAG) and Bakt_805R (GACTACHVGGGTATCTAATCC) were used to amplify the bacterial 16S rRNA genes from the isolated DNA. The primers were complemented with 454 adapters and sample-specific barcodes ([@B28]). PCRs were prepared in triplicate and amplified under conditions that have been described elsewhere ([@B29]). PCR products were confirmed using agarose gel electrophoresis, and the triplicate products were pooled and purified using an Agencourt AMPure system (Beckham Coulter Genomics). Purified PCR products were quantified using a Qubit fluorometer (Invitrogen) and mixed into equimolar amounts. The mixed pool of PCR products was sequenced from the reverse primer direction using the Roche/454 GS Titanium technology platform (Branford, CT, USA).

Taxonomic analysis. {#h3.4}
-------------------

The sequence processing was performed mainly as described previously ([@B28]). In brief, sequences were checked for quality, and those that were \<400 bp in length excluding the primer sequence, contained incorrect primer sequences, or contained any ambiguous base were discarded. Remaining sequences were then subjected to complete linkage clustering using the pyrosequencing pipeline at the Ribosomal Database Project (RDP) ([@B30]), with a conservative 5% dissimilarity to define operational taxonomic units (OTUs). The most abundant sequence from each OTU was selected as a representative sequence and was taxonomically classified by BLAST searching against a local BLAST database comprised of 600,316 bacterial 16S rRNA gene sequences longer than 1,200 bp with good Pintail scores from RDP v.10.7. The OTU inherited the taxonomy (down to the genus level) of the best-scoring RDP hit that fulfilled the criteria of ≥95% identity over an alignment of length ≥380 bp. Assignment of sequences to samples was based on the 5-bp barcode.

Statistical analyses. {#h3.5}
---------------------

Samples that contained fewer than 1,000 sequences (in total, five samples) were excluded from the analysis. The statistical analyses were performed in the multivariate statistical software Past ([@B31]). Principal-component analysis (PCA) based on abundance data from sequences classified to the genus level was performed to find clustering patterns among the subjects. Validation of the clustering pattern was confirmed with an np-MANOVA using Bray, Curtis distances and 10,000 permutations. Calculations of the individual stability of the microbiotas were performed with Bray, Curtis metrics. Differences in the relative abundances of specific bacterial groups or between similarity indexes were tested with Mann-Whitney's test and the Kruskal-Wallis test, respectively. Simpson's index of diversity was used to assess the microbial diversity in the samples ([@B32]).

Nucleotide sequence accession number. {#h3.6}
-------------------------------------

The sequences have been deposited in the sequence read archive (SRA) at the NCBI under the accession number [SRP045781](http://www.ncbi.nlm.nih.gov/sra/?term=SRP045781).

SUPPLEMENTAL MATERIAL {#h4}
=====================

###### 

Characteristics of the participants according to *Campylobacter*-positive or -negative stool culture.

###### 

Table S1, DOC file, 0.1 MB.
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